Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Codice" (184)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
(Codice) 184 products
WHO-DDD
IP
CI
CM
Gabapentin Viatris 100 mg
50
7.69
17.00
10 %
Capsules: Gabapentinum 100 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Gabapentin Viatris 100 mg
100
13.53
27.80
10 %
Capsules: Gabapentinum 100 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Gabapentin Viatris 300 mg
50
16.59
35.40
10 %
Capsules: Gabapentinum 300 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Gabapentin Viatris 300 mg
100
33.16
54.45
10 %
Capsules: Gabapentinum 300 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Gabapentin Viatris 400 mg
50
23.86
43.75
10 %
Capsules: Gabapentinum 400 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Gabapentin Viatris 400 mg
100
45.00
68.05
10 %
Capsules: Gabapentinum 400 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
Camzyos 2.5 mg
28
PR
PR
k.A.
Capsules: Mavacamtenum 2.5 mg
Bristol-Myers Squibb SA
B
FB
G
IP
Camzyos 5 mg
28
PR
PR
k.A.
Capsules: Mavacamtenum 5 mg
Bristol-Myers Squibb SA
B
FB
G
IP
Camzyos 10 mg
28
PR
PR
k.A.
Capsules: Mavacamtenum 10 mg
Bristol-Myers Squibb SA
B
FB
G
IP
Camzyos 15 mg
28
PR
PR
k.A.
Capsules: Mavacamtenum 15 mg
Bristol-Myers Squibb SA
B
FB
G
IP
CI
CM
Amlodipin Viatris 5 mg
30
PR
PR
k.A.
Tablets: Amlodipinum 5 mg
Viatris Pharma GmbH
B
FB
G
IP
CI
CM
Amlodipin Viatris 5 mg
100
PR
PR
k.A.
Tablets: Amlodipinum 5 mg
Viatris Pharma GmbH
B
FB
G
IP
CI
CM
Amlodipin Viatris 10 mg
30
PR
PR
k.A.
Tablets: Amlodipinum 10 mg
Viatris Pharma GmbH
B
FB
G
IP
CI
CM
Amlodipin Viatris 10 mg
100
PR
PR
k.A.
Tablets: Amlodipinum 10 mg
Viatris Pharma GmbH
B
FB
G
IP
CI
CM
Telfastin 120
10
PR
PR
k.A.
überzogene Tabletten: Fexofenadini Hydrochloridum 120 mg
Opella Healthcare
Switzerland AG
D
FB
G
IP
CI
CM
Telfastin 120
30
PR
PR
k.A.
überzogene Tabletten: Fexofenadini Hydrochloridum 120 mg
Opella Healthcare
Switzerland AG
D
FB
G
IP
CM
Telfastin 180
10
PR
PR
k.A.
überzogene Tabletten: Fexofenadini Hydrochloridum 180 mg
Opella Healthcare
Switzerland AG
D
FB
G
L
IP
CI
Plaquenil
30 Tablet(s)
3.77
8.45
10 %
Coated tablets: Hydroxychloroquini Sulfas 200 mg
Sanofi-Aventis
(Suisse) SA
B / SL / SO
FB
G
L
IP
CI
Revatio
90 Tablet(s)
507.84
599.40
20 %
Coated tablets: Sildenafilum 20 mg
Viatris Pharma GmbH
B / SL / SO
FB
G
L
IP
CI
Vascord 40mg/10mg
28 Tablet(s)
24.27
44.25
20 %
Coated tablets: 2 Active Agents
A. Menarini GmbH
B / SL / SO
FB
G
L
IP
CI
Vascord 40mg/10mg
98 Tablet(s)
73.48
100.75
20 %
Coated tablets: 2 Active Agents
A. Menarini GmbH
B / SL / SO
FB
G
IP
CI
Fluimucil 100
30
2.03
3.75
10 %
granulato: Acetylcysteinum 100 mg
Zambon Svizzera SA
D / SL / SO
FB
G
IP
CI
Fluimucil 600
30
10.49
20.25
10 %
granulato: Acetylcysteinum 600 mg
Zambon Svizzera SA
● 
B / SL / SO
FB
G
IP
CI
Multilind
24 ml
2.34
6.80
10 %
Nystatinum 100 UI
Dermapharm AG
B / SL / SG
FB
G
IP
Methotrexat Teva Onco 50
mg/2 ml
8.06
17.45
10 %
Infusion solution: Methotrexatum 50mg / 2ml
Teva Pharma AG
A / SL / SG
FB
G
IP
Methotrexat Teva Onco 500
mg/20 ml
52.47
76.65
10 %
Infusion solution: Methotrexatum 500mg / 20ml
Teva Pharma AG
A / SL / SG
FB
G
IP
Methotrexat Teva Onco
5000 mg/50 ml
314.54
377.50
10 %
Infusion solution: Methotrexatum 5000mg / 50ml
Teva Pharma AG
● 
A / SL / SG
FB
G
IP
Vincristine Pfizer
5 1 Durchstechflasche(n) à 1 mg
58.73
83.80
10 %
Injection solution: Vincristini Sulfas 1 mg/ml
Pfizer AG
A / SL / SG
FB
G
IP
Vincristine Pfizer
5 1 Durchstechflasche(n) à 2 mg
101.06
132.40
10 %
Injection solution: Vincristini Sulfas 1 mg/ml
Pfizer AG
A / SL / SG
FB
G
IP
CI
Zolmitriptan Spirig 2.5
2 Tablet(s)
6.56
15.75
10 %
Melting tablets: Zolmitriptanum 2.5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Zolmitriptan Spirig 2.5
6 Tablet(s)
18.85
38.05
10 %
Melting tablets: Zolmitriptanum 2.5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Zolmitriptan Spirig 2.5
12 Tablet(s)
33.07
54.35
10 %
Melting tablets: Zolmitriptanum 2.5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CM
Docetaxel Zentiva 20 mg/1 ml
Durchstechflasche(n)
64.96
90.95
10 %
Concentrate for infusion: Docetaxelum 20 mg/ml
Helvepharm AG
A / SL / SG
FB
G
IP
CM
Docetaxel Zentiva 80 mg/4 ml
Durchstechflasche(n)
254.75
308.85
10 %
Concentrate for infusion: Docetaxelum 80mg / 4ml
Helvepharm AG
A / SL / SG
FB
G
IP
Etoposid Sandoz 100 mg/5 ml
Durchstechflasche(n) à 100 mg
21.70
41.30
10 %
Concentrate for infusion: Etoposidum 100mg / 5ml
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
Etoposid Sandoz 1000
mg/50 ml
Durchstechflasche(n) à 1000 mg
175.00
217.30
10 %
Concentrate for infusion: Etoposidum 1000mg / 50ml
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Methylphenidat-Mepha LA
10mg
30
13.21
27.45
10 %
Delayed release capsules: Methylphenidati Hydrochloridum 10 mg
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
Methylphenidat-Mepha LA
10mg
100
37.42
59.35
10 %
Delayed release capsules: Methylphenidati Hydrochloridum 10 mg
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
Methylphenidat-Mepha LA
20mg
30
26.42
46.75
10 %
Delayed release capsules: Methylphenidati Hydrochloridum 20 mg
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
Methylphenidat-Mepha LA
20mg
100
74.84
102.30
10 %
Delayed release capsules: Methylphenidati Hydrochloridum 20 mg
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
Methylphenidat-Mepha LA
30mg
30
34.31
55.80
10 %
Delayed release capsules: Methylphenidati Hydrochloridum 30 mg
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
Methylphenidat-Mepha LA
30mg
100
97.22
128.00
10 %
Delayed release capsules: Methylphenidati Hydrochloridum 30 mg
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
Methylphenidat-Mepha LA
40mg
30
39.62
61.90
10 %
Delayed release capsules: Methylphenidati Hydrochloridum 40 mg
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
Methylphenidat-Mepha LA
40mg
100
112.27
145.30
10 %
Delayed release capsules: Methylphenidati Hydrochloridum 40 mg
Mepha Pharma AG
● 
A+ / SL / SG
FB
G
IP
CI
Nevirapin Sandoz Retard 400 mg
30
162.68
203.15
10 %
Delayed release tablets: Nevirapinum 400 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
Paliperidon Sandoz 6 mg
28
113.36
146.55
10 %
Delayed release tablets: Paliperidonum 6 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Atovaquon-Proguanil-Mepha 250 / 100
12
20.30
39.70
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
A / SL / SG
FB
G
IP
CI
Irbesartan-HCT-Mepha
150mg/12.5mg
28 Tablet(s)
9.25
18.80
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Irbesartan-HCT-Mepha
150mg/12.5mg
98 Tablet(s)
29.84
50.65
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Irbesartan-HCT-Mepha
300mg/25mg
28 Tablet(s)
12.64
26.80
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Irbesartan-HCT-Mepha
300mg/25mg
98 Tablet(s)
43.63
66.50
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Risperidon Sandoz 0,5 mg
‐
I
20 Tablet(s)
4.31
9.05
10 %
Coated tablets: Risperidonum
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Risperidon Sandoz 0,5 mg
‐
I
60 Tablet(s)
10.99
20.80
10 %
Coated tablets: Risperidonum
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Risperidon Sandoz 1 mg
20 Tablet(s)
7.94
17.30
10 %
Coated tablets: Risperidonum 1 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Risperidon Sandoz 1 mg
60 Tablet(s)
19.86
39.20
10 %
Coated tablets: Risperidonum 1 mg
Sandoz
Pharmaceuticals AG
● 
B / SL / SG
FB
G
IP
CI
Risperidon Sandoz 2 mg
20 Tablet(s)
13.02
27.25
10 %
Coated tablets: Risperidonum 2 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Risperidon Sandoz 2 mg
60 Tablet(s)
32.86
54.10
10 %
Coated tablets: Risperidonum 2 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Risperidon Sandoz 3 mg
20 Tablet(s)
18.66
37.80
10 %
Coated tablets: Risperidonum 3 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Risperidon Sandoz 3 mg
60 Tablet(s)
48.63
72.25
10 %
Coated tablets: Risperidonum 3 mg
Sandoz
Pharmaceuticals AG
● 
B / SL / SG
FB
G
IP
CI
Risperidon Sandoz 4 mg
20 Tablet(s)
16.88
35.80
10 %
Coated tablets: Risperidonum 4 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Risperidon Sandoz 4 mg
60 Tablet(s)
63.17
88.90
10 %
Coated tablets: Risperidonum 4 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Risperidon Sandoz 6 mg
20 Tablet(s)
40.79
63.25
10 %
Coated tablets: Risperidonum 6 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Risperidon Sandoz 6 mg
60 Tablet(s)
120.42
154.65
10 %
Coated tablets: Risperidonum 6 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Aripiprazol Xiromed 5 mg
28
28.41
49.00
10 %
Tablets: Aripiprazolum 5 mg
Xiromed SA
B / SL / SG
FB
G
IP
CI
Aripiprazol Xiromed 5 mg
98
79.81
108.00
10 %
Tablets: Aripiprazolum 5 mg
Xiromed SA
B / SL / SG
FB
G
IP
Aripiprazol Xiromed 10 mg
28
30.16
51.00
10 %
Tablets: Aripiprazolum 10 mg
Xiromed SA
B / SL / SG
FB
G
IP
Aripiprazol Xiromed 10 mg
98
85.91
115.00
10 %
Tablets: Aripiprazolum 10 mg
Xiromed SA
B / SL / SG
FB
G
IP
Aripiprazol Xiromed 15 mg
28
32.77
54.00
10 %
Tablets: Aripiprazolum 15 mg
Xiromed SA
B / SL / SG
FB
G
IP
Aripiprazol Xiromed 15 mg
98
89.39
119.00
10 %
Tablets: Aripiprazolum 15 mg
Xiromed SA
B / SL / SG
FB
G
IP
Aripiprazol Xiromed 30 mg
28
59.77
85.00
10 %
Tablets: Aripiprazolum 30 mg
Xiromed SA
B / SL / SG
FB
G
IP
Aripiprazol Xiromed 30 mg
98
159.08
199.00
10 %
Tablets: Aripiprazolum 30 mg
Xiromed SA
B / SL / SG
FB
G
IP
CI
Carvedilol Sandoz 6.25
-
T
14 Tablet(s)
5.15
10 %
Tablets: Carvedilolum 6.25 mg
Sandoz
Pharmaceuticals AG
● 
B / SL / SG
FB
G
IP
CI
Carvedilol Sandoz 25
30 Tablet(s)
11.53
25.55
10 %
Tablets: Carvedilolum 25 mg
Sandoz
Pharmaceuticals AG
● 
B / SL / SG
FB
G
IP
CI
Carvedilol Sandoz 25
100 Tablet(s)
34.34
55.80
10 %
Tablets: Carvedilolum 25 mg
Sandoz
Pharmaceuticals AG
● 
B / SL / SG
FB
G
IP
Darunavir Mylan 600 mg
60
320.37
384.20
10 %
Tablets: Darunavirum 600 mg
Mylan Pharma GmbH
A / SL / SG
FB
G
L
IP
CI
CM
Vildagliptin Sandoz 50 mg
28
10.45
20.20
10 %
Tablets: Vildagliptinum 50 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
CM
Vildagliptin Sandoz 50 mg
112
41.80
64.40
10 %
Tablets: Vildagliptinum 50 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Desloratadin-Mepha 5
10 Tablet(s)
2.86
7.40
10 %
Filmtablette: Desloratadinum 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Desloratadin-Mepha 5
30 Tablet(s)
8.46
17.90
10 %
Filmtablette: Desloratadinum 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Desloratadin-Mepha 5
50 Tablet(s)
13.83
28.20
10 %
Filmtablette: Desloratadinum 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Daptomycin Labatec 350 mg
74.36
101.75
10 %
poudre pour solution injectable ou pour perfusion: Daptomycinum 350 mg
Labatec Pharma SA
A / SL / SG
FB
G
L
IP
Daptomycin Labatec 350 mg
5
371.81
443.25
10 %
poudre pour solution injectable ou pour perfusion: Daptomycinum 350 mg
Labatec Pharma SA
A / SL / SG
FB
G
L
IP
Daptomycin Labatec 500 mg
106.23
138.35
10 %
poudre pour solution injectable ou pour perfusion: Daptomycinum 500 mg
Labatec Pharma SA
A / SL / SG
FB
G
L
IP
Daptomycin Labatec 500 mg
5
531.16
626.15
10 %
poudre pour solution injectable ou pour perfusion: Daptomycinum 500 mg
Labatec Pharma SA
A / SL / SG
FB
G
L
IP
CI
Cimzia
2 syringe(s)
902.63
1051.45
10 %
Injection solution: Certolizumabum Pegolum 200 mg/ml
UCB-Pharma SA
B / SL
FB
G
L
IP
CI
PP
Stelara 45 mg
3074.64
3397.50
10 %
Injection solution: Ustekinumabum 45mg / 0.5ml
Janssen-Cilag AG
B / SL
FB
G
L
IP
CI
Erelzi 50 mg/1 ml
2
426.38
505.90
10 %
Injection solution in prefilled syringe: Etanerceptum 50 mg/ml
Sandoz
Pharmaceuticals AG
B / SL
FB
G
L
IP
CI
Klean-Prep
4 Sachet(s)
11.54
25.55
10 %
Soluble Powder: 5 Active Agents
Norgine AG
B / SL
FB
G
IP
CI
Plenvu
3
13.65
27.95
10 %
Soluble Powder: 4 Active Agents
Soluble Powder: 3 Active Agents
Soluble Powder: 2 Active Agents
Norgine AG
B / SL
FB
G
IP
CI
Toplexil
150 ml
3.81
8.45
10 %
Sirup: Oxomemazinum 1.65mg / 5ml
Opella Healthcare
Switzerland AG
● 
B / SL
FB
G
L
IP
Imfinzi 120 mg/2.4 ml
574.06
675.40
10 %
Concentrate for infusion: Durvalumabum 120mg / 2.4ml
AstraZeneca AG
A / SL
FB
G
L
IP
Keytruda 100 mg/4 ml
2
4407.68
4763.85
10 %
Concentrate for infusion: Pembrolizumabum 100mg / 4ml
MSD Merck Sharp &
Dohme AG
A / SL
FB
G
L
IP
PP
Opdivo 40 mg/4 ml
Durchstechflasche(n)
539.55
635.80
10 %
Concentrate for infusion: Nivolumabum 40mg / 4ml
Bristol-Myers Squibb SA
A / SL
FB
G
L
IP
PP
Opdivo 100 mg/10 ml
Durchstechflasche(n)
1348.86
1540.85
10 %
Concentrate for infusion: Nivolumabum 100mg / 10ml
Bristol-Myers Squibb SA
A / SL
FB
G
L
IP
PP
Opdivo 240 mg/24 ml
3084.05
3407.15
10 %
Concentrate for infusion: Nivolumabum 240mg / 24ml
Bristol-Myers Squibb SA
A / SL
FB
G
L
IP
Truxima 500 mg/50 ml
1061.49
1225.70
10 %
Concentrate for infusion: Rituximabum 500mg / 50ml
iQone Healthcare
Switzerland SA
A / SL
FB
G
L
IP
Truxima 100 mg/10 ml
2
426.05
505.50
10 %
Concentrate for infusion: Rituximabum 100mg / 10ml
iQone Healthcare
Switzerland SA
A / SL
FB
G
IP
CI
Apranax 550 mg
20 Tablet(s)
3.97
8.65
10 %
Coated tablets: Naproxenum Natricum 550 mg
Atnahs Pharma
Switzerland AG
B / SL
FB
G
IP
CI
Apranax 550 mg
50 Tablet(s)
8.76
18.25
10 %
Coated tablets: Naproxenum Natricum 550 mg
Atnahs Pharma
Switzerland AG
● 
B / SL
FB
G
L
IP
CI
PP
Entresto 100 mg
56 Tablet(s)
123.90
158.65
10 %
Coated tablets: 2 Active Agents
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
PP
Entresto 100 mg
168
371.70
443.10
10 %
Coated tablets: 2 Active Agents
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Ezetimib Rosuvastatin
Zentiva 10 mg / 10 mg
30
19.44
38.70
10 %
Coated tablets: 2 Active Agents
Helvepharm AG
B / SL
FB
G
L
IP
CI
Ezetimib Rosuvastatin
Zentiva 10 mg / 10 mg
90
56.14
80.85
10 %
Coated tablets: 2 Active Agents
Helvepharm AG
B / SL
FB
G
L
IP
CI
PP
Olumiant 4 mg
28
871.24
1016.60
10 %
Coated tablets: Baricitinibum 4 mg
Eli Lilly (Suisse) SA
B / SL
FB
G
IP
CI
Rimactazid 150/75
60 Tablet(s)
38.20
60.25
10 %
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
● 
A / SL
FB
G
L
IP
CI
Vokanamet 150 mg / 1000 mg
60 Tablet(s)
66.08
92.25
10 %
Coated tablets: 2 Active Agents
Janssen-Cilag AG
B / SL
FB
G
L
IP
CI
Vokanamet 150 mg / 1000 mg
180 Tablet(s)
198.23
243.95
10 %
Coated tablets: 2 Active Agents
Janssen-Cilag AG
B / SL
FB
G
IP
CI
COLCTAB 1 mg
10
11.13
25.10
10 %
Tablets: Colchicinum 1 mg
Streuli Pharma AG
A / SL
FB
G
L
IP
Pemazyre 9 mg
14
7907.33
8351.00
10 %
Tablets: Pemigatinibum 9 mg
Incyte Biosciences
International Sàrl
A / SL
FB
G
IP
CI
Livostin Augentropfen
4 ml
7.22
13.30
10 %
Augentropfensuspension: Levocabastinum
JNTL Consumer Health II
(Switzerland) GmbH
● 
D / SL
FB
G
L
IP
CI
Hulio 40 mg/0.8 ml
421.64
500.45
10 %
Injektionslösung im Fertigpen: Adalimumabum 40mg / 0.8ml
Mylan Pharma GmbH
B / SL
FB
G
L
IP
CI
Hulio 40 mg/0.8 ml
2
843.28
984.50
10 %
Injektionslösung im Fertigpen: Adalimumabum 40mg / 0.8ml
Mylan Pharma GmbH
B / SL
FB
G
IP
CI
Zoloft
60 ml
20.01
39.35
10 %
Konzentrat zur Herstellung einer Lösung zum Einnehmen: Sertralinum 20 mg/ml
Viatris Pharma GmbH
● 
B / SL
FB
G
IP
CI
TOBI
56 ampoule(s)
2326.52
2613.10
10 %
Lösung zur Inhalation mit einem Vernebler: Tobramycinum 300mg / 5ml
Mylan Pharma GmbH
A / SL
FB
G
L
IP
PP
Herceptin subkutan
600mg/5ml
1706.26
1932.85
10 %
Lösung zur subkutanen Injektion: Trastuzumabum 600mg / 5ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
Veklury
444.46
526.65
10 %
Pulver für Konzentrat zur Herstellung einer Infusionslösung: Remdesivirum 100 mg
Gilead Sciences
Switzerland Sàrl
A / SL
FB
G
L
IP
PP
Adcetris
Durchstechflasche(n)
3358.75
3688.70
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Brentuximabum Vedotinum 50 mg
Takeda Pharma AG
A / SL
FB
G
L
IP
PP
Adcetris
2 Durchstechflasche(n)
6717.49
7131.45
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Brentuximabum Vedotinum 50 mg
Takeda Pharma AG
A / SL
FB
G
L
IP
Mycamine 100 mg
Durchstechflasche(n)
424.35
503.55
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Micafunginum 100 mg
Astellas Pharma AG
A / SL
FB
G
L
IP
Ogivri 150 mg
475.67
562.45
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum 150 mg
Mylan Pharma GmbH
A / SL
FB
G
L
IP
Padcev 20 mg
681.24
798.45
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Enfortumabum Vedotinum 20 mg
Astellas Pharma AG
A / SL
FB
G
L
IP
Padcev 30 mg
1028.09
1189.05
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Enfortumabum Vedotinum 30 mg
Astellas Pharma AG
A / SL
FB
G
IP
CI
V/S
Comirnaty® 30
Mikrogramm/Dosis
10
PR
PR
k.A.
Pfizer AG
B
FB
G
IP
V/S
Comirnaty® 10
Mikrogramm/Dosis
10
PR
PR
k.A.
Pfizer AG
B
FB
G
IP
CI
V/S
Comirnaty® 30
Mikrogramm/Dosis
195
PR
PR
k.A.
Pfizer AG
B
FB
G
IP
V/S
Comirnaty® 10
Mikrogramm/Dosis
195
PR
PR
k.A.
Pfizer AG
B
FB
G
IP
CI
V/S
Comirnaty®
Original/Omicron BA.1
15/15 µg pro Dosis
gebrauchsfertige
Injektionsdispersion für
Personen ab 18 Jahren
10
PR
PR
k.A.
2 Active Agents
Pfizer AG
B
FB
G
IP
CI
V/S
Comirnaty®
Original/Omicron BA.1
15/15 µg pro Dosis
gebrauchsfertige
Injektionsdispersion für
Personen ab 18 Jahren
195
PR
PR
k.A.
2 Active Agents
Pfizer AG
B
FB
G
IP
CI
Pelsano med onguent
60 g
3.55
6.55
k.A.
2 Active Agents
VERFORA SA
D
FB
G
IP
CI
Pelsano med onguent
100 g
PR
PR
k.A.
2 Active Agents
VERFORA SA
D
FB
G
IP
CI
Visine Classic
15 ml
PR
PR
k.A.
Eye drops: Tetryzolini Hydrochloridum
JNTL Consumer Health II
(Switzerland) GmbH
D
FB
G
IP
CI
Visine Classic Hydro 0,5
mg/ml
15 ml
PR
PR
k.A.
Eye drops: Tetryzolini Hydrochloridum
JNTL Consumer Health II
(Switzerland) GmbH
D
FB
G
IP
Methotrexat Teva Onco 5
mg/2 ml
2.99
7.55
k.A.
Infusion solution: Methotrexatum 5mg / 2ml
Teva Pharma AG
A
FB
G
IP
Methotrexat Teva Onco
1000 mg/10 ml
90.25
120.00
k.A.
Infusion solution: Methotrexatum 1000mg / 10ml
Teva Pharma AG
A
FB
G
IP
Lidocain Streuli 20 mg/ml
10 1 ampoule(s) à 2 ml
PR
10.35
k.A.
Injection solution: Lidocaini Hydrochloridum Monohydricum 20 mg/ml
Streuli Pharma AG
B
FB
G
IP
Lidocain Streuli 20 mg/ml
10 1 ampoule(s) à 5 ml
PR
12.20
k.A.
Injection solution: Lidocaini Hydrochloridum Monohydricum 20 mg/ml
Streuli Pharma AG
● 
B
FB
G
IP
Lidocain Streuli 20 mg/ml
50 1 ampoule(s) à 2 ml
PR
29.00
k.A.
Injection solution: Lidocaini Hydrochloridum Monohydricum 20 mg/ml
Streuli Pharma AG
B
FB
G
IP
Lidocain Streuli 20 mg/ml
50 1 ampoule(s) à 5 ml
PR
35.00
k.A.
Injection solution: Lidocaini Hydrochloridum Monohydricum 20 mg/ml
Streuli Pharma AG
● 
B
FB
G
IP
CI
Tora-dol 30 mg
5 ampoule(s)
6.26
15.40
k.A.
Injection solution: Ketorolacum Trometamolum 30 mg/ml
Atnahs Pharma
Switzerland AG
B
FB
G
IP
Erelzi 50 mg/1 ml
PR
PR
k.A.
Injection solution in prefilled syringe: Etanerceptum 50 mg/ml
Sandoz
Pharmaceuticals AG
B
FB
G
IP
Erelzi 50 mg/1 ml
4
PR
PR
k.A.
Injection solution in prefilled syringe: Etanerceptum 50 mg/ml
Sandoz
Pharmaceuticals AG
B
FB
G
IP
Erelzi 50 mg/1 ml
12
PR
PR
k.A.
Injection solution in prefilled syringe: Etanerceptum 50 mg/ml
Sandoz
Pharmaceuticals AG
B
FB
G
IP
Fasturtec 1.5 mg / 1 ml
3 Kombipackung(en) à 1.5 mg
PR
PR
k.A.
poudre et solvant pour solution à diluer pour perfusion: Rasburicasum 1.5 mg
Sanofi-Aventis
(Suisse) SA
A
FB
G
IP
Fasturtec 1.5 mg / 1 ml
3 x 1.5 mg
PR
PR
k.A.
poudre et solvant pour solution à diluer pour perfusion: Rasburicasum 1.5 mg
Sanofi-Aventis
(Suisse) SA
A
FB
G
IP
Fasturtec 7.5 mg / 5 ml
Kombipackung(en) à 7.5 mg
PR
PR
k.A.
poudre et solvant pour solution à diluer pour perfusion: Rasburicasum 7.5 mg
Sanofi-Aventis
(Suisse) SA
A
FB
G
IP
CI
Nicorette Original-Aroma 4 mg
30 Tablet(s)
PR
PR
k.A.
Chewing Gum: Nicotinum 4 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Freshfruit 4 mg
30 Tablet(s)
PR
PR
k.A.
Chewing Gum: Nicotinum 4 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Polar Mint 4 mg
30 Tablet(s)
PR
PR
k.A.
Chewing Gum: Nicotinum 4 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Original-Aroma 4 mg
105 Tablet(s)
PR
PR
k.A.
Chewing Gum: Nicotinum 4 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Freshfruit 4 mg
105 Tablet(s)
PR
PR
k.A.
Chewing Gum: Nicotinum 4 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Polar Mint 4 mg
105 Tablet(s)
PR
PR
k.A.
Chewing Gum: Nicotinum 4 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
Dafalgan Direct 1000 mg
(Rote Beeren)
16
PR
PR
k.A.
Granulate: Paracetamolum 1000 mg
UPSA Switzerland AG
B
FB
G
IP
Elzonris 1mg / ml
PR
PR
k.A.
Concentrate for infusion: Tagraxofuspum 1 mg/ml
Stemline Therapeutics
Switzerland GmbH
A
FB
G
IP
Etoposid Sandoz 400 mg/20 ml
Durchstechflasche(n) à 400 mg
78.00
105.95
k.A.
Concentrate for infusion: Etoposidum 400mg / 20ml
Sandoz
Pharmaceuticals AG
A
FB
G
IP
PP
Opdivo 120 mg/12 ml
PR
PR
k.A.
Concentrate for infusion: Nivolumabum 120mg / 12ml
Bristol-Myers Squibb SA
A
FB
G
IP
Sarclisa 500 mg/25 mL
PR
PR
k.A.
Concentrate for infusion: Isatuximabum 500mg / 25ml
Sanofi-Aventis
(Suisse) SA
A
FB
G
IP
Vegzelma 100 mg/4 ml
PR
PR
k.A.
Concentrate for infusion: Bevacizumabum 100mg / 4ml
iQone Healthcare
Switzerland SA
A
FB
G
IP
Vegzelma 400 mg/16 ml
PR
PR
k.A.
Concentrate for infusion: Bevacizumabum 400mg / 16ml
iQone Healthcare
Switzerland SA
A
FB
G
IP
Imipenem-Cilastatin
Labatec
10 x 500 mg
PR
PR
k.A.
Dry substance: 2 Active Agents
Labatec Pharma SA
A
FB
G
IP
CI
Nicorette Invisi 10 mg/16 h
14 plaster(s)
PR
PR
k.A.
Transdermal System: Nicotinum 15.75 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Nicorette Invisi 25 mg/ 16 h
14 plaster(s)
PR
PR
k.A.
Transdermal System: Nicotinum 39.37 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
Paliperidon Sandoz 6 mg
56
PR
PR
k.A.
Delayed release tablets: Paliperidonum 6 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
Atovaquon-Proguanil-Mepha
Junior 62.5 / 25
12
PR
PR
k.A.
Coated tablets: 2 Active Agents
Mepha Pharma AG
● 
A
FB
G
IP
CI
Atovaquon-Proguanil-Mepha 250 / 100
24
PR
PR
k.A.
Coated tablets: 2 Active Agents
Mepha Pharma AG
A
FB
G
IP
Pemazyre 9 mg
28
PR
PR
k.A.
Tablets: Pemigatinibum 9 mg
Incyte Biosciences
International Sàrl
A
FB
G
IP
CI
Stugeron
‐
I
25 Tablet(s)
PR
PR
k.A.
Tablets: Cinnarizinum 25 mg
JNTL Consumer Health II
(Switzerland) GmbH
B
FB
G
IP
Lidocain Streuli 20 mg/ml
Durchstechflasche(n) à 50 ml
3.40
8.00
k.A.
Injektionslösung (Durchstechflaschen): Lidocaini Hydrochloridum Monohydricum 20 mg/ml
Streuli Pharma AG
B
FB
G
IP
Lidocain Streuli 20 mg/ml
10 1 Durchstechflasche(n) à 50 ml
PR
51.65
k.A.
Injektionslösung (Durchstechflaschen): Lidocaini Hydrochloridum Monohydricum 20 mg/ml
Streuli Pharma AG
B
FB
G
IP
CI
Redoxon Orangenaroma
60 Tablet(s)
PR
PR
k.A.
Kautabletten zuckerfrei: Acidum Ascorbicum 500 mg
Bayer (Schweiz) AG
D
FB
G
IP
CI
V/S
Comirnaty
195
PR
PR
k.A.
Konzentrat zur Herstellung einer Injektionsdispersion: Tozinameranum 225 µg
Pfizer AG
B
FB
G
IP
CI
Regaine 2 %
60 ml
PR
PR
k.A.
Solution: Minoxidilum 20 mg/ml
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Regaine 2 %
3 x 60 ml
PR
PR
k.A.
Solution: Minoxidilum 20 mg/ml
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
CM
Amavita Flumol Grippe
12
PR
PR
k.A.
Pulver zur Herstellung einer Lösung zum Einnehmen: 4 Active Agents
Amavita Health Care AG
D
FB
G
IP
CI
CM
Coop Vitality Flumol
Grippe
12
PR
PR
k.A.
Pulver zur Herstellung einer Lösung zum Einnehmen: 4 Active Agents
Coop Vitality Health
Care GmbH
D
FB
G
IP
CI
CM
SUN STORE Flumol Grippe
12
PR
PR
k.A.
Pulver zur Herstellung einer Lösung zum Einnehmen: 4 Active Agents
Sun Store Health Care AG
D
FB
G
IP
CI
Procto-Glyvenol
30 g
PR
PR
k.A.
Rektalcreme: 2 Active Agents
GSK Consumer
Healthcare Schweiz AG
D
FB
G
IP
CI
Fluimucil 600
10
PR
PR
k.A.
granulato: Acetylcysteinum 600 mg
Zambon Svizzera SA
D
FB
G
IP
CI
Mounjaro 2.5 mg
4
PR
PR
k.A.
solution pour injection en stylo pré-rempli: Tirzepatidum 2.5mg / 0.5ml
Eli Lilly (Suisse) SA
B
FB
G
IP
V/S
Efluelda 0.7 ml
0.7 ml
PR
PR
k.A.
suspension injectable en seringue préremplie: 3 Active Agents
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
V/S
Efluelda 0.7 ml
0.7 ml
PR
PR
k.A.
suspension injectable en seringue préremplie: 3 Active Agents
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
V/S
Efluelda 0.7 ml
5 x 0.7 ml
PR
PR
k.A.
suspension injectable en seringue préremplie: 3 Active Agents
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
V/S
Efluelda 0.7 ml
5 x 0.7 ml
PR
PR
k.A.
suspension injectable en seringue préremplie: 3 Active Agents
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
V/S
Efluelda 0.7 ml
10 x 0.7 ml
PR
PR
k.A.
suspension injectable en seringue préremplie: 3 Active Agents
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
V/S
Efluelda 0.7 ml
10 x 0.7 ml
PR
PR
k.A.
suspension injectable en seringue préremplie: 3 Active Agents
Sanofi-Aventis
(Suisse) SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2023
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home